PELP1: A novel therapeutic target for hormonal cancers

IUBMB Life

Volumn 62, Issue 3, 2010, Pages 162-169

  Chakravarty, Dimple ^a   Tekmal, Rajeshwar Rao ^a   Vadlamudi, Ratna K ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Coregulators; Estrogen receptor; Hormonal signaling; PELP1; Therapy resistance

Indexed keywords

DASATINIB; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; PARGYLINE; PROTEIN PELP 1; RESVERATROL; ROSCOVITINE; UNCLASSIFIED DRUG; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; PELP1 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

CELL CYCLE PROGRESSION; ENZYME INHIBITION; ESTROGEN SYNTHESIS; GENE TARGETING; GENOMICS; HORMONAL CARCINOGENESIS; HORMONAL THERAPY; HUMAN; HYPERTENSION; METASTASIS; NONHUMAN; PROGNOSIS; PROTEIN EXPRESSION; PROTO ONCOGENE; REVIEW; SIGNAL TRANSDUCTION; BREAST TUMOR; DRUG EFFECT; DRUG RESISTANCE; FEMALE; GENETICS; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; NEOPLASM METASTASIS; NEOPLASMS, HORMONE-DEPENDENT; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS;

EID: 77951129233     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.287     Document Type: Review

References (65)

1. Green, K. A. and Carroll, J. S. (2007) Oestrogen-receptor-mediated transcription and the influence of co-factors and chromatin state. Nat. Rev. Cancer 7, 713-722.
2. Heldring, N., Pike, A., Andersson, S., Matthews, J., Cheng, G., Hartman, J., Tujague, M., Strom, A., Treuter, E., Warner, M., and Gustafsson, J. A. (2007) Estrogen receptors: how do they signal and what are their targets. Physiol. Rev. 87, 905-931.
3. Lewis-Wambi, J. S. and Jordan, V. C. (2005) Treatment of postmenopausal breast cancer with selective estrogen receptor modulators (SERMs). Breast Dis. 24, 93-105. (Pubitemid 44241531)
4. Leary, A. and Dowsett, M. (2006) Combination therapy with aromatase inhibitors: the next era of breast cancer treatment. Br. J. Cancer. 95, 661-666.
5. Song, R. X., Zhang, Z., and Santen, R. J. (2005) Estrogen rapid action via protein complex formation involving ERalpha and Src. Trends Endocrinol. Metab. 16, 347-353.
6. Losel, R. and Wehling, M. (2003) Nongenomic actions of steroid hormones. Nat. Rev. Mol. Cell. Biol. 4, 46-56.
7. Bjornstrom, L. and Sjoberg, M. (2005) Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol. Endocrinol. 19, 833-842.
8. Mckenna, N. J., Lanz, R. B., and O'Malley, B. W. (1999) Nuclear receptor coregulators: cellular and molecular biology. Endocr. Rev. 20, 321-344.
9. Barnes, C. J., Vadlamudi, R. K., and Kumar, R. (2004) Novel estrogen receptor coregulators and signaling molecules in human diseases. Cell. Mol. Life Sci. 61, 281-291.
10. Han, S. J., Demayo, F. J., Xu, J., Tsai, S. Y., Tsai, M. J., and O'Malley, B. W. (2006) Steroid receptor coactivator (SRC)-1 and SRC-3 differentially modulate tissue-specific activation functions of the progesterone receptor. Mol. Endocrinol. 20, 45-55.
11. Xu, J., Qiu, Y., Demayo, F. J., Tsai, S. Y., Tsai, M. J., and O'Malley, B. W. (1998) Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science 279, 1922-1925. (Pubitemid 28168645)
12. Xu, J., Liao, L., Ning, G., Yoshida-Komiya, H., Deng, C., and O'Malley, B. W. (2000) The steroid receptor coactivator SRC-3 (p/CIP/ RAC3/AIB1/ACTR/TRAM- 1) is required for normal growth, puberty, female reproductive function, and mammary gland development. Proc. Natl. Acad. Sci. U. S. A. 97, 6379-6384.
13. Vadlamudi, R. K., Wang, R. A., Mazumdar, A., Kim, Y., Shin, J., Sahin, A., and Kumar, R. (2001) Molecular cloning and characterization of PELP1, a novel human coregulator of estrogen receptor alpha. J. Biol. Chem. 276, 38272-38279.
14. Cheskis, B. J., Greger, J., Cooch, N., Mcnally, C., Mclarney, S., Lam, H. S., Rutledge, S., Mekonnen, B., Hauze, D., Nagpal, S., and Freedman, L. P. (2008) MNAR plays an important role in ERa activation of Src/MAPK and PI3K/Akt signaling pathways. Steroids 73, 901-905.
15. Nair, S. S., Mishra, S. K., Yang, Z., Balasenthil, S., Kumar, R., and Vadlamudi, R. K. (2004) Potential role of a novel transcriptional coactivator PELP1 in histone H1 displacement in cancer cells. Cancer Res. 64, 6416-6423. (Pubitemid 39297895)
16. Barletta, F., Wong, C. W., Mcnally, C., Komm, B. S., Katzenellenbogen, B., and Cheskis, B. J. (2004) Characterization of the interactions of estrogen receptor and MNAR in the activation of cSrc. Mol. Endocrinol. 18, 1096-1108.
17. Vadlamudi, R. K., Manavathi, B., Balasenthil, S., Nair, S. S., Yang, Z., Sahin, A. A., and Kumar, R. (2005) Functional implications of altered subcellular localization of PELP1 in breast cancer cells. Cancer Res. 65, 7724-7732. (Pubitemid 41297247)
18. Unni, E., Sun, S., Nan, B., Mcphaul, M. J., Cheskis, B., Mancini, M. A., and Marcelli, M. (2004) Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Cancer Res. 64, 7156-7168. (Pubitemid 39331031)
19. Nair, S. S., Guo, Z., Mueller, J. M., Koochekpour, S., Qiu, Y., Tekmal, R. R., Schule, R., Kung, H. J., Kumar, R., and Vadlamudi, R. K. (2007) PELP1/MNAR enhances androgen receptor functions through LIM-only coactivator FHL2. Mol. Endocrinol. 21, 613-624.
20. Rajhans, R., Nair, H. B., Nair, S. S., Cortez, V., Ikuko, K., Kirma, N. B., Zhou, D., Holden, A. E., Brann, D. W., Chen, S., Tekmal, R. R., and Vadlamudi, R. K. (2008) Modulation of in situ estrogen synthesis by PELP1: potential ER autocrine signaling loop in breast cancer cells. Mol. Endocrinol. 22, 649-664.
21. Kayahara, M., Ohanian, J., Ohanian, V., Berry, A., Vadlamudi, R., and Ray, D. W. (2008) MNAR functionally interacts with both NH2- and COOH-terminal GR domains to modulate transactivation. Am. J. Physiol. Endocrinol. Metab. 295, E1047-E1055.
22. Khan, M. M., Hadman, M., De Sevilla, L. M., Mahesh, V. B., Buccafusco, J., Hill, W. D., and Brann, D. W. (2006) Cloning, distribution, and colocalization of MNAR/PELP1 with glucocorticoid receptors in primate and nonprimate brain. Neuroendocrinology 84, 317-329. (Pubitemid 46398359)
23. Singh, R. R., Gururaj, A. E., Vadlamudi, R. K., and Kumar, R. (2006) 9-cis-retinoic acid upregulates expression of transcriptional coregulator PELP1, a novel coactivator of RXRalpha pathway. J. Biol. Chem. 281, 15394-14404
24. Choi, Y. B., Ko, J. K., and Shin, J. (2004) The transcriptional corepressor, PELP1, recruits HDAC2 and masks histones using two separate domains. J. Biol. Chem. 279, 50930-50941.
25. Vadlamudi, R. K. and Kumar, R. (2007) Functional and biological properties of the nuclear receptor coregulator PELP1/MNAR. Nucl. Recept. Signal. 5, 1-9.
26. Greger, J. G., Fursov, N., Cooch, N., Mclarney, S., Freedman, L. P., Edwards, D. P., and Cheskis, B. J. (2007) Phosphorylation of MNAR promotes estrogen activation of phosphatidylinositol 3-kinase. Mol. Cell. Biol. 27, 1904-1913.
27. Nagpal, J. K., Nair, S., Chakravarty, D., Rajhans, R., Pothana, S., Brann, D. W., Tekmal, R. R., and Vadlamudi, R. K. (2008) Growth factor regulation of estrogen receptor coregulator PELP1 functions via protein kinase A pathway. Mol. Cancer. Res. 6, 851-861.
28. Nair, B. C., Nair, S., Chakravarty, D., Rajhans, R., Cortez, V., Tekmal, R. R., and Vadlamudi, R. K. (2008) PELP1/MNAR: a novel CDKs substrate and regulator of pRb/E2F pathway. Proc. Am. Assn. Cancer Res. 2008, 4222.
29. Vadlamudi, R. K., Balasenthil, S., Broaddus, R. R., Gustafsson, J. A., and Kumar, R. (2004) Deregulation of estrogen receptor coactivator proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor in human endometrial tumors. J. Clin. Endocrinol. Metab. 89, 6130-6138.
30. Mishra, S. K., Mazumdar, A., Vadlamudi, R. K., Li, F., Wang, R. A., Yu, W., Jordan, V. C., Santen, R. J., and Kumar, R. (2003) MICoA, a novel metastasis-associated protein 1 (MTA1) interacting protein coactivator, regulates estrogen receptor-alpha transactivation functions. J. Biol. Chem. 278, 19209-19219.
31. Rosendorff, A., Sakakibara, S., Lu, S., Kieff, E., Xuan, Y., Dibacco, A., Shi, Y., Shi, Y., and Gill, G. (2006) NXP-2 association with SUMO-2 depends on lysines required for transcriptional repression. Proc. Natl. Acad. Sci. U. S. A. 103, 5308-5313.
32. Nair, S. S., Nair, B. C., Chakravarty, D., Tekmal, R. R., and Vadlamudi, R. K. (2009) Regulation of histone H3 methylation by ER coregulator PELP1: a novel paradigm in coregulator function. Proc. Am. Assn. Cancer Res. 2009, 3848.
33. Manavathi, B. and Kumar, R. (2005) Steering estrogen signals from the plasma membrane to the nucleus: two sides of the coin. J. Cell. Physiol. 207, 594-604.
34. Nagpal, J., Nair, S., Pothana, S., Tekmal, R., Kumar, R., and Vadlamudi, R. (2006) Growth factor regulation of PELP1/MNAR functions:Role of PKA-dependent phosphorylation. Proc. Am. Assn. Cancer Res. 47, 2933.
35. Migliaccio, A., Di, D. M., Castoria, G., Nanayakkara, M., Lombardi, M., De, F. A., Bilancio, A., Varricchio, L., Ciociola, A., and Auricchio, F. (2005) Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action. Cancer. Res. 65, 10585-10593.
36. Manavathi, B., Nair, S. S., Wang, R. A., Kumar, R., and Vadlamudi, R. K. (2005) Proline-, glutamic acid-, and leucine-rich protein-1 is essential in growth factor regulation of signal transducers and activators of transcription 3 activation. Cancer Res. 65, 5571-5577. (Pubitemid 40911157)
37. Rayala, S. K., Hollander, P., Balasenthil, S., Molli, P. R., Bean, A. J., Vadlamudi, R. K., Wang, R. A., and Kumar, R. (2006) Hepatocyte growth factor-regulated tyrosine kinase substrate (HRS) interacts with PELP1 and activates MAPK. J. Biol. Chem. 281, 4395-4403.
38. Balasenthil, S. and Vadlamudi, R. K. (2003) Functional interactions between the estrogen receptor coactivator PELP1/MNAR and retinoblastoma protein. J. Biol. Chem. 278, 22119-22127.
39. Haas, D., White, S. N., Lutz, L. B., Rasar, M., and Hammes, S. R. (2005) The modulator of nongenomic actions of the estrogen receptor (MNAR) regulates transcription-independent androgen receptor-mediated signaling: evidence that MNAR participates in G protein-regulated meiosis in Xenopus laevis oocytes. Mol. Endocrinol. 19, 2035-2046.
40. Habashy, H. O., Powe, D. G., Rakha, E. A., Ball, G., Macmillan, R. D., Green, A. R., and Ellis, I. O. (2009) The prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype. Breast Cancer. Res. Treat. ePub ahead of print.
41. Kumar, R., Zhang, H., Holm, C., Vadlamudi, R. K., Landberg, G., and Rayala, S. K. (2009) Extranuclear coactivator signaling confers insensitivity to tamoxifen. Clin. Cancer. Res. 15, 4123-4130.
42. Rajhans, R., Nair, S., Holden, A. H., Kumar, R., Tekmal, R. R., and Vadlamudi, R. K. (2007) Oncogenic potential of the nuclear receptor coregulator proline-, glutamic acid-, leucine-rich protein 1/modulator of the nongenomic actions of the estrogen receptor. Cancer Res. 67, 5505-5512. (Pubitemid 46997292)
43. Dimple, C., Nair, S. S., Rajhans, R., Pitcheswara, P. R., Liu, J., Balasenthil, S., Le, X. F., Burow, M. E., Auersperg, N., Tekmal, R. R., Broaddus, R. R., and Vadlamudi, R. K. (2008) Role of PELP1/MNAR signaling in ovarian tumorigenesis. Cancer Res. 68, 4902-4909.
44. Rajhans, R. and Vadlamudi, R. K. (2006) Comprehensive analysis of recent biochemical and biologic findings regarding a newly discovered NR coregulator PELP1/MNAR. Clin. Exp. Metastasis 23, 1-7.
45. Greger, J. G., Guo, Y., Henderson, R., Ross, J. F., and Cheskis, B. J. (2005) Characterization of MNAR expression. Steroids 71, 317-322.
46. Vadlamudi, R. K., Bagheri-Yarmand, R., Yang, Z., Balasenthil, S., Nguyen, D., Sahin, A. A., Den, H. P., and Kumar, R. (2004) Dynein light chain 1, a p21-activated kinase 1-interacting substrate, promotes cancerous phenotypes. Cancer Cell. 5, 575-585. (Pubitemid 38748919)
47. Popov, V. M., Zhou, J., Shirley, L. A., Quong, J., Yeow, W. S., Wright, J. A., Wu, K., Rui, H., Vadlamudi, R. K., Jiang, J., Kumar, R., Wang, C., and Pestell, R. G. (2009) The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling. Cancer. Res. 69, 5752-5760.
48. Vadlamudi, R. K., Balasenthil, S., Sahin, A. A., Kies, M., Weber, R. S., Kumar, R., and El-Naggar, A. K. (2005) Novel estrogen receptor coactivator PELP1/MNAR gene and ERbeta expression in salivary duct adenocarcinoma: potential therapeutic targets. Hum. Pathol. 36, 670-675.
49. Grivas, P. D., Tzelepi, V., Sotiropoulou-Bonikou, G., Kefalopoulou, Z., Papavassiliou, A. G., and Kalofonos, H. (2009) Expression of ERalpha, ERbeta and co-regulator PELP1/MNAR in colorectal cancer: prognostic significance and clinicopathologic correlations. Cell. Oncol. 31, 235-247.
50. Tzelepi, V., Grivas, P., Kefalopoulou, Z., Kalofonos, H., Varakis, J. N., and Sotiropoulou-Bonikou, G. (2009) Expression of estrogen receptor co-regulators NCoR and PELP1 in epithelial cells and myofibroblasts of colorectal carcinomas: cytoplasmic translocation of NCoR in epithelial cells correlates with better prognosis. Virchows Arch. 454, 41-53.
51. Marquez-Garban, D. C., Chen, H. W., Fishbein, M. C., Goodglick, L., and Pietras, R. J. (2007) Estrogen receptor signaling pathways in human non-small cell lung cancer. Steroids 72, 135-143. (Pubitemid 46273500)
52. Gururaj, A. E., Rayala, S. K., Vadlamudi, R. K., and Kumar, R. (2006) Novel mechanisms of resistance to endocrine therapy: genomic and nongenomic considerations. Clin. Cancer Res. 12, 1001s-1007s.
53. Wong, C. W., Mcnally, C., Nickbarg, E., Komm, B. S., and Cheskis, B. J. (2002) Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade. Proc. Natl. Acad. Sci. U. S. A. 99, 14783-14788.
54. Chakravarty, D., Santhamma, B., Nair, B. C., Rajib, R., Nair, S., Agyin, S., Tekmal, R. R., and Vadlamudi, R. K. (2008) PELP1/MNAR couples estrogen signaling to cytoskeleton through ILK axis. Proc. Am. Assn. Cancer Res. 2008, 5451.
55. Mishra, S. K., Talukder, A. H., Gururaj, A. E., Yang, Z., Singh, R. R., Mahoney, M. G., Franci, C., Vadlamudi, R. K., and Kumar, R. (2004) Upstream determinants of estrogen receptor-alpha regulation of metastatic tumor antigen 3 pathway. J. Biol. Chem. 279, 32709-32715.
56. Simpson, E. R. and Davis, S. R. (2001) Minireview: aromatase and the regulation of estrogen biosynthesis-some new perspectives. Endocrinology 142, 4589-4594.
57. Vadlamudi, R. K., Rajhans, R., Chakravarty, D., Nair, B., Nair, S. S., Evans, D. B., Chen, S., and Tekmal, R. R. (2009) Regulation of aromatase induction by nuclear receptor coregulator PELP1. J. Steroid. Biochem. Mol. Biol. doi: 10.1016.
58. Adjei, A. A. and Hidalgo, M. (2005) Intracellular signal transduction pathway proteins as targets for cancer therapy. J. Clin. Oncol. 23, 5386-5403.
59. Chakravarty, C., Nair, S., Nair, C. B., Wang, L., Bandyopadhyay, A. M., Agyin, J. K., Francis, L., Sun, L., Yeh, I., Tekmal, R. R., and Vadlamudi, R. K. (2009) Therapeutic potential of blocking ER nongenomic actions on ER-positive metastasis. Proc. Am. Assn. Cancer Res. 2009, 2387.
60. Chandrasekharan, N. B., Nair, S. S., Chakravarty, D., Yew, R. P., Tekmal, R. R., and Vadlamudi, R. K. (2009) Modulation of hormone therapy resistance by CDK2-PELP1 axis. Cancer Res. 69, 211S.
61. Rayala, S. K., Mascarenhas, J., Vadlamudi, R. K., and Kumar, R. (2006) Altered localization of a coactivator sensitizes breast cancer cells to tumor necrosis factor-induced apoptosis. Mol. Cancer Ther. 5, 230-237.
62. Lan, F., Nottke, A. C., and Shi, Y. (2008) Mechanisms involved in the regulation of histone lysine demethylases. Curr. Opin. Cell. Biol. 20, 316-325.
63. Ohshiro, K., Rayala, S. K., Kondo, S., Gaur, A., Vadlamudi, R. K., El-Naggar, A. K., and Kumar, R. (2007) Identifying the estrogen receptor coactivator PELP1 in autophagosomes. Cancer Res. 67, 8164-8171. (Pubitemid 47395152)
64. Janes, K. A., Calvo, P., and Alonso, M. J. (2001) Polysaccharide colloidal particles as delivery systems for macromolecules. Adv. Drug. Deliv. Rev. 47, 83-97.
65. Chakravarty, D., Nair, B. C., Nair, S. S., Tekmal, R. R., and Vadlamudi, R. K. (2009) Potential role of estrogen receptor coregulator in mitosis. Cancer Res. 69, 311S.